Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Effects of yoga, strength training and advice on back pain: a randomized controlled trial.

Brämberg EB, Bergström G, Jensen I, Hagberg J, Kwak L.

BMC Musculoskelet Disord. 2017 Mar 29;18(1):132. doi: 10.1186/s12891-017-1497-1.

2.

Predicting outcome in traumatic brain injury: Sharing experience of pilot traumatic brain injury registry.

Pal R, Munivenkatappa A, Agrawal A, Menon GR, Galwankar S, Mohan PR, Kumar SS, Subrahmanyam BV.

Int J Crit Illn Inj Sci. 2016 Jul-Sep;6(3):127-132.

3.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

4.

Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.

Silverberg ND, Crane PK, Dams-O'Connor K, Holdnack J, Ivins BJ, Lange RT, Manley GT, McCrea M, Iverson GL.

J Neurotrauma. 2017 Jan 15;34(2):363-371. doi: 10.1089/neu.2016.4443. Epub 2016 Jun 27.

PMID:
27188248
5.

Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

Dwan K, Altman DG, Clarke M, Gamble C, Higgins JP, Sterne JA, Williamson PR, Kirkham JJ.

PLoS Med. 2014 Jun 24;11(6):e1001666. doi: 10.1371/journal.pmed.1001666. eCollection 2014 Jun. Review.

6.

The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.

Kahan BC, Jairath V, Doré CJ, Morris TP.

Trials. 2014 Apr 23;15:139. doi: 10.1186/1745-6215-15-139.

7.

Managing common complex symptomatic epilepsies: tumors and trauma: american epilepsy society - 2012 annual course summary.

Burneo JG, Sirven JI, Kiesel LW, Vecht CJ, Jehi L, Chung SS, Uhm J, Politsky JM, Chang EF, Husain AM, Tatum WO, Meador KJ, Noe K, Hesdorffer DC, Herman ST, Wiebe S, Engel J Jr, Schrader S, Parko KL, Dichter MA, Kwan P, Kossoff E, Sperling MR.

Epilepsy Curr. 2013 Sep;13(5):232-5. doi: 10.5698/1535-7597-13.5.232. No abstract available.

8.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D.

BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.

9.

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.

10.

Guidelines for randomized clinical trial protocol content: a systematic review.

Tetzlaff JM, Chan AW, Kitchen J, Sampson M, Tricco AC, Moher D.

Syst Rev. 2012 Sep 24;1:43. doi: 10.1186/2046-4053-1-43. Review.

11.

Association between social influences and drinking outcomes across three years.

Stout RL, Kelly JF, Magill M, Pagano ME.

J Stud Alcohol Drugs. 2012 May;73(3):489-97.

12.

Baseline matters: the importance of covariation for baseline severity in the analysis of clinical trials.

Nunes EV, Pavlicova M, Hu MC, Campbell AN, Miele G, Hien D, Klein DF.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):446-52. doi: 10.3109/00952990.2011.596980.

13.

Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage.

Risselada R, Lingsma HF, Molyneux AJ, Kerr RS, Yarnold J, Sneade M, Steyerberg EW, Sturkenboom MC.

BMC Med Res Methodol. 2010 Sep 29;10:86. doi: 10.1186/1471-2288-10-86.

14.

Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review.

Yu LM, Chan AW, Hopewell S, Deeks JJ, Altman DG.

Trials. 2010 May 18;11:59. doi: 10.1186/1745-6215-11-59. Review.

15.

Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?

Fernandez Y Garcia E, Nguyen H, Duan N, Gabler NB, Kravitz RL.

Health Serv Res. 2010 Feb;45(1):283-301. doi: 10.1111/j.1475-6773.2009.01064.x.

16.

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.

Sun X, Briel M, Busse JW, Akl EA, You JJ, Mejza F, Bala M, Diaz-Granados N, Bassler D, Mertz D, Srinathan SK, Vandvik PO, Malaga G, Alshurafa M, Dahm P, Alonso-Coello P, Heels-Ansdell DM, Bhatnagar N, Johnston BC, Wang L, Walter SD, Altman DG, Guyatt GH.

Trials. 2009 Nov 9;10:101. doi: 10.1186/1745-6215-10-101. Review.

17.

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

Chan AW, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG.

BMJ. 2008 Dec 4;337:a2299. doi: 10.1136/bmj.a2299.

18.

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI.

PLoS Med. 2008 Aug 5;5(8):e165; discussion e165. doi: 10.1371/journal.pmed.0050165.

19.

Selection in reported epidemiological risks: an empirical assessment.

Kavvoura FK, Liberopoulos G, Ioannidis JP.

PLoS Med. 2007 Mar;4(3):e79.

Supplemental Content

Support Center